Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 52,500
+100 (0.19%)
At close: Jan 9, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 390.38 billion as of January 9, 2026.
Market Cap
390.38B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
52,500.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 390.38B, an increase of 73.84%. That is a compound annual growth rate of 7,945.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 390.38B | - |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 909.01T |
| SK hynix | 501.27T |
| LG Energy Solution | 88.45T |
| Samsung Biologics | 79.67T |
| Hyundai Motor Company | 74.83T |
| HD Hyundai Heavy Industries | 57.73T |
| SK Square | 57.06T |
| Doosan Enerbility | 55.02T |